ETANERREL 25 MG PFS

About

Etanercept, known as ETANERREL, is a dimeric fusion protein that acts as a competitive inhibitor of tumor necrosis factor-alpha (TNF-alpha). It consists of the extracellular ligand-binding portion of the human 75-kilodalton (p75) TNF receptor linked to the Fc portion of human IgG1. By binding to TNF-alpha, etanercept prevents its interaction with cell surface TNF receptors, thereby reducing TNF-alpha-mediated inflammation. This mechanism helps to alleviate symptoms and slow the progression of various autoimmune and inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, as well as plaque psoriasis.

Classified as a biologic disease-modifying antirheumatic drug (DMARD), ETANERREL is administered via subcutaneous injection, often in a pre-filled syringe (PFS) for convenience. Its targeted action on TNF-alpha makes it an effective treatment option for conditions characterized by excessive TNF-alpha activity, offering significant clinical benefits in terms of pain reduction, improved physical function, and disease remission, ultimately enhancing patient quality of life.

Uses

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Plaque Psoriasis

Directions For Use

Administer subcutaneously using the pre-filled syringe as prescribed by your doctor. Follow aseptic technique and rotate injection sites.

Benefits

• Reduces joint inflammation and pain
• Slows structural joint damage
• Improves physical mobility and function
• Effective for skin lesions in psoriasis
• Provides sustained disease control
• Enhances overall quality of life

Side Effects

• Injection site reactions (redness, itching)
• Upper respiratory infections
• Headache
• Nausea
• Dizziness
• Rash
• Increased risk of serious infections
• Allergic reactions
• Abdominal pain
• Fever
• Cough
• Sinusitis

Safety Measures

• Alcohol - No specific contraindication, but excessive alcohol may worsen liver function or other systemic effects. Discuss with your doctor.
• Pregnancy - Use only if potential benefits outweigh risks; consult a healthcare provider before use. Data on human pregnancy are limited.
• Breastfeeding - Small amounts may be excreted in breast milk; caution is advised. Seek medical advice to determine the best course of action.
• Liver - Use with caution in patients with hepatic impairment; monitor liver enzymes periodically during treatment.
• Kidney - No specific dose adjustment is typically required for renal impairment; use as directed by your physician.
• Lung - Increased risk of infections, including tuberculosis; screen for latent TB before starting treatment and monitor for new respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.